The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
1061803910 10618039 10 F 201509 20160818 20141202 20160822 EXP BR-ROCHE-779934 ROCHE 75.20 YR F Y 75.00000 KG 20160822 MD BR BR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
1061803910 10618039 1 PS MABTHERA RITUXIMAB 1 Intravenous (not otherwise specified) U 103705 SOLUTION FOR INFUSION
1061803910 10618039 2 SS MABTHERA RITUXIMAB 1 Intravenous (not otherwise specified) RECEIVED THE MOST RECENT INFUSION ON 17/NOV/2014, 15/JUL/2015. U 103705 SOLUTION FOR INFUSION
1061803910 10618039 3 SS MABTHERA RITUXIMAB 1 Intravenous (not otherwise specified) U 103705 SOLUTION FOR INFUSION /cycle
1061803910 10618039 4 SS MABTHERA RITUXIMAB 1 Intravenous (not otherwise specified) U 103705 500 MG SOLUTION FOR INFUSION
1061803910 10618039 5 SS RIVOTRIL CLONAZEPAM 1 Unknown DAILY U 17533 2.5 MG
1061803910 10618039 6 C ESOMEPRAZOLE ESOMEPRAZOLE 1 0
1061803910 10618039 7 C OMEPRAZOLE. OMEPRAZOLE 1 0
1061803910 10618039 8 C ARAVA LEFLUNOMIDE 1 Unknown 0 20 MG TABLET QD
1061803910 10618039 9 C CYMBALTA DULOXETINE HYDROCHLORIDE 1 0
1061803910 10618039 10 C LISADOR DIPYRONEPROMETHAZINE HYDROCHLORIDE 1 0
1061803910 10618039 11 C FLANAX (BRAZIL) 2 0
1061803910 10618039 12 C DAFLON DIOSMINHESPERIDIN 1 Unknown 0 1000 MG
1061803910 10618039 13 C VENLAFAXINE VENLAFAXINE HYDROCHLORIDE 1 Unknown 0 150 MG TABLET QD
1061803910 10618039 14 C SYNTHROID LEVOTHYROXINE SODIUM 1 0
1061803910 10618039 15 C TAMARINE (BRAZIL) 2 0
1061803910 10618039 16 C OMEGA 3 OMEGA-3 FATTY ACIDS 1 Unknown 0 TABLET
1061803910 10618039 17 C NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Unknown 20 MG AND 40 MG 0 TABLET QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
1061803910 10618039 1 Rheumatoid arthritis
1061803910 10618039 5 Product used for unknown indication
1061803910 10618039 8 Rheumatoid arthritis

Outcome of event

Event ID CASEID OUTC COD
1061803910 10618039 OT
1061803910 10618039 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
1061803910 10618039 Arthralgia
1061803910 10618039 Arthropathy
1061803910 10618039 Bedridden
1061803910 10618039 Body height decreased
1061803910 10618039 Fall
1061803910 10618039 Femur fracture
1061803910 10618039 Gastric disorder
1061803910 10618039 Malaise
1061803910 10618039 Movement disorder
1061803910 10618039 Pneumonia
1061803910 10618039 Tracheobronchitis
1061803910 10618039 Upper limb fracture
1061803910 10618039 Urinary tract infection
1061803910 10618039 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
1061803910 10618039 1 2007 20101015 0
1061803910 10618039 2 20091001 0